Table 4.
Observed rates of unadjusted intraoperative and postoperative outcomes
| Outcome | Induction FOLFOX vs. CP | Induction Chemotherapy vs. No Induction | ||||
|---|---|---|---|---|---|---|
| FOLFOX (n=70) | CP (n=239) | P | Induction (n=309) | No Induction (n=142) | P | |
| Length of stay, days | 9 (6 to 28) | 10 (5 to 144) | <0.001 | 10 (5 to 144) | 10 (1 to 71) | 0.86 |
| Minimally invasive | 46 (66) | 105 (44) | 0.002 | 151 (49) | 60 (42) | 0.22 |
| R1 resection | 1 (1) | 11 (5) | 0.31 | 12 (4) | 4 (3) | 0.79 |
| Serious complication | 12 (17) | 41 (17) | >0.99 | 53 (17) | 29 (20) | 0.43 |
| In-hospital mortality | 0 (0) | 7 (3) | 0.36 | 7 (2) | 2 (1) | 0.73 |
| 30-day mortality | 0 (0) | 5 (2) | 0.59 | 5 (2) | 2 (1) | >0.99 |
| 90-day mortality | 1 (1) | 13 (5) | 0.20 | 14 (5) | 4 (3) | 0.45 |
Data are no. (%) or median (range). Fisher’s exact test and the Wilcoxon rank-sum test were used. CP, carboplatin plus paclitaxel.